These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 17273852)
1. Risk adjustment policy options for casemix funding: international lessons in financing reform. Antioch KM; Ellis RP; Gillett S; Borovnicar D; Marshall RP Eur J Health Econ; 2007 Sep; 8(3):195-212. PubMed ID: 17273852 [TBL] [Abstract][Full Text] [Related]
2. The risk-adjusted vision beyond casemix (DRG) funding in Australia. International lessons in high complexity and capitation. Antioch KM; Walsh MK Eur J Health Econ; 2004 Jun; 5(2):95-109. PubMed ID: 15452744 [TBL] [Abstract][Full Text] [Related]
3. Funding issues for Victorian hospitals: the risk-adjusted vision beyond casemix funding. Antioch K; Walsh M Aust Health Rev; 2000; 23(3):145-53. PubMed ID: 11186047 [TBL] [Abstract][Full Text] [Related]
4. Prospective payment to encourage system wide quality improvement. McNair P; Borovnicar D; Jackson T; Gillett S Med Care; 2009 Mar; 47(3):272-8. PubMed ID: 19194336 [TBL] [Abstract][Full Text] [Related]
5. DRG cost weights--getting it right. Phelan PD; Tate R; Webster F; Marshall RP Med J Aust; 1998 Oct; 169(S1):S36-8. PubMed ID: 9830409 [TBL] [Abstract][Full Text] [Related]
6. Casemix funding for acute hospital inpatient services in Australia. Duckett SJ Med J Aust; 1998 Oct; 169(S1):S17-21. PubMed ID: 9830405 [TBL] [Abstract][Full Text] [Related]
7. Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 2007 rates; fiscal year 2007 occupational mix adjustment to wage index; health care infrastructure improvement program; selection criteria of loan program for qualifying hospitals engaged in cancer-related health care and forgiveness of indebtedness; and exclusion of vendor purchases made under the competitive acquisition program (CAP) for outpatient drugs and biologicals under part B for the purpose of calculating the average sales price (ASP). Final rules and interim final rule with comment period. Centers for Medicare and Medicaid Services (CMS), HHS Fed Regist; 2006 Aug; 71(160):47869-8351. PubMed ID: 16921666 [TBL] [Abstract][Full Text] [Related]
8. Casemix funding for a specialist paediatrics hospital: a hedonic regression approach. Bridges JF; Hanson RM Aust Health Rev; 2000; 23(3):171-5. PubMed ID: 11186050 [TBL] [Abstract][Full Text] [Related]
9. Casemix funding of hospitals: objectives and objections. Palmer G Health Care Anal; 1996 Aug; 4(3):185-93. PubMed ID: 10162141 [TBL] [Abstract][Full Text] [Related]
10. Potential loss of revenue due to errors in clinical coding during the implementation of the Malaysia diagnosis related group (MY-DRG Zafirah SA; Nur AM; Puteh SEW; Aljunid SM BMC Health Serv Res; 2018 Jan; 18(1):38. PubMed ID: 29370785 [TBL] [Abstract][Full Text] [Related]
11. Estimates of costs by DRG in Sydney teaching hospitals: an application of the Yale cost model. Palmer G; Aisbett C; Fetter R; Winchester L; Reid B; Rigby E Aust Health Rev; 1991; 14(3):314-34. PubMed ID: 10117339 [TBL] [Abstract][Full Text] [Related]
12. A study of the relationship between severity of illness and hospital cost in New Jersey hospitals. Averill RF; McGuire TE; Manning BE; Fowler DA; Horn SD; Dickson PS; Coye MJ; Knowlton DL; Bender JA Health Serv Res; 1992 Dec; 27(5):587-606; discussion 607-12. PubMed ID: 1464535 [TBL] [Abstract][Full Text] [Related]
13. Inpatient transfer episodes among aged Medicare beneficiaries. Buczko W Health Care Financ Rev; 1993; 15(2):71-87. PubMed ID: 10135346 [TBL] [Abstract][Full Text] [Related]
14. The annual variation in activity and funding for acute public hospitals in NSW, 1988-89 to 1992-93. Sibbritt D; Gibberd R Aust Health Rev; 1996; 19(1):52-67. PubMed ID: 10157537 [TBL] [Abstract][Full Text] [Related]
15. Hospital payment arrangements to encourage efficiency: the case of Victoria, Australia. Duckett SJ Health Policy; 1995 Nov; 34(2):113-34. PubMed ID: 10153481 [TBL] [Abstract][Full Text] [Related]
16. Casemix funding in Australia. Braithwaite J; Hindle D; Phelan PD; Hanson R Med J Aust; 1998 Jun; 168(11):558-62. PubMed ID: 9640306 [TBL] [Abstract][Full Text] [Related]
17. Severity variations within DRGs: measurement of hospital effects by use of data on significant secondary diagnoses and procedures. Hindle D; Degeling P; van der Wel O Aust Health Rev; 1998; 21(1):37-49. PubMed ID: 10181671 [TBL] [Abstract][Full Text] [Related]
18. Using a public hospital funding model to strengthen a case for improved nutritional care in a cancer setting. Boltong AG; Loeliger JM; Steer BL Aust Health Rev; 2013 Jun; 37(3):286-90. PubMed ID: 23731960 [TBL] [Abstract][Full Text] [Related]
19. Financial risk and hospital cost in stratified, peripheral vascular surgical DRGs without complications and comorbidities. Munoz E; Cohen JR; Goldstein J; Benacquista T; Mulloy K; Wise L Ann Vasc Surg; 1989 Apr; 3(2):170-6. PubMed ID: 2504266 [TBL] [Abstract][Full Text] [Related]
20. Supply-side risk adjustment and outlier payment policy. Mougeot M; Naegelen F J Health Econ; 2008 Sep; 27(5):1196-200. PubMed ID: 18597877 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]